The immunosuppressive tumour network: Myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

Medicine and Dentistry

• Antigen Presenting Cell 33%
• Cancer Research 33%
• Cell Population 33%
• Clinical Intervention 33%
• Flexibility 33%
• Immunity 66%
• Immunocompetent Cell 33%
• Immunosuppressive Drug 100%
• Immunosuppressive Treatment 33%
• Immunotherapy 33%
• Malignant Neoplasm 33%
• Myeloid-Derived Suppressor Cell 100%
• Natural Killer T Cell 100%
• Neoplasm 100%
• Regulatory T Cell 100%
• T Cell 33%
• Target Cell 33%
• Tumor Microenvironment 100%
• Tumor Model 33%
• Tumor Progression 33%

Keyphrases

• Antigen-presenting Cells 25%
• Cancer Immunotherapy 25%
• Cancer Research 25%
• Cell Focusing 25%
• Cell Population 25%
• Clinical Intervention 25%
• Clinical Reports 25%
• Common Pathway 25%
• Immune Cells 25%
• Immune Suppression 25%
• Immune-suppressive 50%
• Immunocombination Therapy 25%
• Immunosuppressive Tumor 100%
• In Vitro Tumor Models 25%
• Major Components 25%
• Myeloid-derived Suppressor Cells 100%
• NKT Cells 100%
• Overlapping Target 25%
• Pathological Conditions 25%
• Regulatory T (Treg) Cells 100%
• Regulatory T Cells 100%
• T Cell Depletion 25%
• Tumor Burden 25%
• Tumor Microenvironment 75%
• Tumor Progression 25%

Immunology and Microbiology

• Antigen-Presenting Cell 20%
• Cell Population 20%
• Immunity 60%
• Immunocompetent Cell 20%
• Immunosuppressive Drug 100%
• Immunotherapy 20%
• Myeloid-Derived Suppressor Cell 100%
• Natural Killer T Cell 100%
• Regulatory T Cell 100%
• T Cell 20%
• Target Cell 20%
• Tumor Volume 20%